BioCentury | Dec 17, 2020
Regulation

As first OTC COVID-19 test raises stakes for consumer guidance, Abbott opts for prescription path

...its lack of temperature cycling.More at-anywhereWednesday saw two other announcements that could advance at-home COVID-19 testing.Sherlock Biosciences Inc....
BioCentury | Sep 19, 2020
Politics, Policy & Law

What it will take to get to mass asymptomatic screening for COVID-19

...But Rahul Dhanda,  co-founder, president and CEO of Sherlock Biosciences Inc....
BioCentury | Sep 12, 2020
Management Tracks

New CEO Hirsch to guide C4 onto NASDAQ; plus Biller adds CFO title at Agios and updates from Sherlock, Lumen and more

...officer. He previously served as EVP, general counsel at Celgene. Martin Madaus joined CRISPR diagnostics play Sherlock Biosciences Inc. as...
BioCentury | Aug 11, 2020
Product Development

Charting a path to COVID-19 testing that supports a return to normalcy

...at personalized medicine company Tempus Labs Inc., and Dhanda is  co-founder, president and CEO of Sherlock Biosciences Inc....
BioCentury | Aug 8, 2020
Product Development

Asymptomatic COVID-19 testing pushes forward, with lessons from cancer

...less data. The only way to answer that question is through more asymptomatic testing, said Sherlock Biosciences Inc....
BioCentury | May 23, 2020
Translation in Brief

A three-compound dengue treatment; plus reversing antibiotic resistance, AbCellera-Lilly, reducing cholesterol with CRISPR and COVID cash for Sherlock

...speed Sherlock’s COVID-19 work The Open Philanthropy Project advanced $7.5 million in grant funding to Sherlock Biosciences Inc....
...dehydrogenase PCSK9 - Proprotein convertase subtilisin/kexin type 9 Danielle Kopke, Staff Writer, and Robin Sawka, Biocentury Staff Sherlock Biosciences Inc. Open...
BioCentury | May 20, 2020
Deals

Mammoth, GSK to take CRISPR diagnostics beyond the centralized lab

...first generation tests. This month, FDA authorized the first CRISPR-based diagnostic test for COVID-19 from Sherlock Biosciences Inc....
BioCentury | May 9, 2020
Product Development

FDA authorizes first COVID-19 test using at-home saliva samples, begins unveiling serological test validation data

...at-home collection of nasal swabs. An at-home sample collection option could eventually be available for Sherlock Biosciences Inc.’s...
...crisis can be found at https://www.biocentury.com/coronavirus Karen Tkach Tuzman, Associate Editor U.S. Food and Drug Administration (FDA) Rutgers University Sherlock Biosciences Inc. Euroimmun...
BioCentury | May 7, 2020
Regulation

CRISPR comes of age years ahead of schedule with first diagnostic authorization

...was expecting it. “This authorization has propelled CRISPR into healthcare,” said Rahul Dhanda, CEO of Sherlock Biosciences Inc....
...Further analysis of the coronavirus crisis can be found at https://www.biocentury.com/coronavirus . Lauren Martz, Senior Editor Sherlock Biosciences Inc. CRISPR COVID-19 cov19dx...
BioCentury | Apr 10, 2020
Management Tracks

Shakeup at Arix; plus Emergent, AlloVir, Asklepios Bio, Morphic, Gritstone and more

...Gene therapy company Asklepios BioPharmaceutical Inc. hired Don Haut as CBO. He was CBO of Sherlock Biosciences Inc....
Items per page:
1 - 10 of 29
BioCentury | Dec 17, 2020
Regulation

As first OTC COVID-19 test raises stakes for consumer guidance, Abbott opts for prescription path

...its lack of temperature cycling.More at-anywhereWednesday saw two other announcements that could advance at-home COVID-19 testing.Sherlock Biosciences Inc....
BioCentury | Sep 19, 2020
Politics, Policy & Law

What it will take to get to mass asymptomatic screening for COVID-19

...But Rahul Dhanda,  co-founder, president and CEO of Sherlock Biosciences Inc....
BioCentury | Sep 12, 2020
Management Tracks

New CEO Hirsch to guide C4 onto NASDAQ; plus Biller adds CFO title at Agios and updates from Sherlock, Lumen and more

...officer. He previously served as EVP, general counsel at Celgene. Martin Madaus joined CRISPR diagnostics play Sherlock Biosciences Inc. as...
BioCentury | Aug 11, 2020
Product Development

Charting a path to COVID-19 testing that supports a return to normalcy

...at personalized medicine company Tempus Labs Inc., and Dhanda is  co-founder, president and CEO of Sherlock Biosciences Inc....
BioCentury | Aug 8, 2020
Product Development

Asymptomatic COVID-19 testing pushes forward, with lessons from cancer

...less data. The only way to answer that question is through more asymptomatic testing, said Sherlock Biosciences Inc....
BioCentury | May 23, 2020
Translation in Brief

A three-compound dengue treatment; plus reversing antibiotic resistance, AbCellera-Lilly, reducing cholesterol with CRISPR and COVID cash for Sherlock

...speed Sherlock’s COVID-19 work The Open Philanthropy Project advanced $7.5 million in grant funding to Sherlock Biosciences Inc....
...dehydrogenase PCSK9 - Proprotein convertase subtilisin/kexin type 9 Danielle Kopke, Staff Writer, and Robin Sawka, Biocentury Staff Sherlock Biosciences Inc. Open...
BioCentury | May 20, 2020
Deals

Mammoth, GSK to take CRISPR diagnostics beyond the centralized lab

...first generation tests. This month, FDA authorized the first CRISPR-based diagnostic test for COVID-19 from Sherlock Biosciences Inc....
BioCentury | May 9, 2020
Product Development

FDA authorizes first COVID-19 test using at-home saliva samples, begins unveiling serological test validation data

...at-home collection of nasal swabs. An at-home sample collection option could eventually be available for Sherlock Biosciences Inc.’s...
...crisis can be found at https://www.biocentury.com/coronavirus Karen Tkach Tuzman, Associate Editor U.S. Food and Drug Administration (FDA) Rutgers University Sherlock Biosciences Inc. Euroimmun...
BioCentury | May 7, 2020
Regulation

CRISPR comes of age years ahead of schedule with first diagnostic authorization

...was expecting it. “This authorization has propelled CRISPR into healthcare,” said Rahul Dhanda, CEO of Sherlock Biosciences Inc....
...Further analysis of the coronavirus crisis can be found at https://www.biocentury.com/coronavirus . Lauren Martz, Senior Editor Sherlock Biosciences Inc. CRISPR COVID-19 cov19dx...
BioCentury | Apr 10, 2020
Management Tracks

Shakeup at Arix; plus Emergent, AlloVir, Asklepios Bio, Morphic, Gritstone and more

...Gene therapy company Asklepios BioPharmaceutical Inc. hired Don Haut as CBO. He was CBO of Sherlock Biosciences Inc....
Items per page:
1 - 10 of 29